NotesFAQContact Us
Collection
Advanced
Search Tips
Back to results
Peer reviewed Peer reviewed
Direct linkDirect link
ERIC Number: EJ1268865
Record Type: Journal
Publication Date: 2020
Pages: 8
Abstractor: As Provided
ISBN: N/A
ISSN: ISSN-0744-8481
EISSN: N/A
Available Date: N/A
DSM-5 Substance Use Disorders among College-Age Young Adults in the United States: Prevalence, Remission and Treatment
Arterberry, Brooke J.; Boyd, Carol J.; West, Brady T.; Schepis, Ty S.; McCabe, Sean Esteban
Journal of American College Health, v68 n6 p650-657 2020
Objective: To determine the prevalence, remission, and treatment associated with DSM-5 substance use disorders (SUDs) among young adults based on college attendance. Participants: The population-based sample included 2,057 young adults aged 19-23 in college/school and 1,213 not currently attending college/school who participated from April 2012 through June 2013. Methods: Face-to-face interviews were conducted as part of a cross-sectional national survey. Results: The prevalence of any past-year DSM-5 SUD was 39.6% among young adults in college and 44.5% among those not attending college. Past-year tobacco use disorder and multiple DSM-5 SUDs were more prevalent among those not attending college. Among those with prior-to-past-year SUDs, abstinent remission was low among college (1.0%) and noncollege (1.9%) young adults. Conclusions: Approximately two in five U.S. college students had at least one past-year DSM-5 SUD. Sustained abstinent remission from SUDs is extremely rare (1-2%) and the majority of those with SUDs do not receive treatment.
Taylor & Francis. Available from: Taylor & Francis, Ltd. 530 Walnut Street Suite 850, Philadelphia, PA 19106. Tel: 800-354-1420; Tel: 215-625-8900; Fax: 215-207-0050; Web site: http://www.tandf.co.uk/journals
Publication Type: Journal Articles; Reports - Research
Education Level: Higher Education; Postsecondary Education
Audience: N/A
Language: English
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) (NIH); National Cancer Institute (NCI) (NIH); National Institute on Drug Abuse (NIDA) (DHHS/PHS)
Authoring Institution: N/A
Grant or Contract Numbers: R01AA025684; T32AA007477; R01CA203809; R01CA212517; R01DA031160; R01DA036541; R01DA043691; R01DA043696
Author Affiliations: N/A